Pharmacovigilance has always been an integral part of drug development. The origins of pharmacovigilance go as far back as 170 years, when medical community of that time started trying to understand the side effects of the used drugs in order to protect patients.
In the last decades pharmacovigilance practices and systems across the globe are changing rapidly significantly due to technological innovations, massive amount of data to review and analyze for biopharmaceutical companies and competent authorities, as well as the increasing importance of patient-centric approach¹. As a result, pressure for compliance placed upon the pharmaceutical industry has drastically increased during this time.
More than ever, the biopharmaceutical industry is in need of powerful systems compliant with current requirements. This demands time and resource of highly experienced industry professionals. As such, companies today look for cost-effective ways to maintain all aspects of pharmacovigilance infrastructure and remain competitive, whilst the ongoing pandemic complicates the situation. This is where pharmacovigilance partners come in.
When outsourcing pharmacovigilance, there are a number of things you must take into consideration:
The Dokumeds pharmacovigilance team is a group of skilled medical professionals led by Kerstin Fleischer, a drug safety expert. Kerstin has over 20 years of managerial experience in the industry and knows how to build efficient communication lines and set up the right priorities. To find out more about how Dokumeds can help streamline your pharmacovigilance infrastructure, book a quick call today.